J&J, Lilly and AZ diabetes medications get another helping of real-world heart benefits
admin 22nd November 2017 Uncategorised 0Last year, real-world data showed that SGLT2 diabetes medications could significantly cut heart failure hospitalizations and all-cause deaths. And now, a new analysis shows that they can also cut the rate of major cardiovascular events in patients new to treatment.
More: J&J, Lilly and AZ diabetes medications get another helping of real-world heart benefits
Source: fierce